HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nusynowitz, M. L. Articles by Dixon, R. S. Search for Related Content PubMed PubMed Citation Articles by Nusynowitz, M. L. Articles by Dixon, R. S.

Blood Clearance Rates of Technetium-99m Albumin Preparations: Concise Communication

William Beaumont Army Medical Center, El Paso, Texas

Correspondence: For reprints contact: Editorial Assistant, Clinical Investigations Service, William Beaumont Army Medical Ctr., El Paso, TX 79920.

ABSTRACT

Technetium-labeled human serum albumin (HSA) is extensively used as a cardiac imaging agent. An evaluation of the blood-clearance rates of electrolytically reduced HSA (EHSA) and four stannous-reduced HSA (SnHSA) preparations was conducted in dogs, and was compared with that of radioiodinated HSA (IHSA). The EHSA was found to have a clearance rate only about 1.5 times that of IHSA, whereas the SnHSA agents were cleared at two to five times the rate of IHSA. Thus, EHSA has definite advantages over SnHSA preparations for the purposes of blood-volume determinations required in quantitative cardiac studies and for the reduction of extravascular background in the accurate delineation of cardiac boundaries.